Will Trump Presidency Spell Big Changes for the FDA?

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Will Trump Presidency Spell Big Changes for the FDA?

The Trump Administration and a Republican-led Congress ushers in a new era that will no doubt affect the FDA in terms of leadership, how regulations will be enforced, or if the rules will be scaled back or scrapped entirely.


It has been just one year since Dr. Robert Califf became the chief of the U.S. Food and Drug Administration, but the agency is no doubt in for a post-election shakeup.

Between a Trump presidency and a pro-business Congress, the next few years might bring about deregulation, and with it the end of numerous consumer protections.

Table of Contents

The Drug and Device Industry

The FDA has long walked the line between patient protection and pressure from the pharmaceutical industry for quicker approvals of drugs and medical devices.

Over the last several years, lawmakers have fought over a myriad of bills that would clear the way for a major change in the way the U.S. prescription drugs and medical devices.

President Trump is likely to enable the pharmaceutical industry to get much of what it wants in terms of deregulation.

Tobacco Regulation

In 2016, long-awaited federal rules to put the regulation of all tobacco products, including e-cigarettes, under the authority of the U.S. Food and Drug Administration (FDA) finally became official.

Prior to the Electronic Nicotine Delivery System rules, E-Cigarettes have been virtually unsupervised by the government.

But on his fifth day in office, President Trump received a letter from Rep.

Duncan Hunter (R-Calif.), asking him to repeal, or at least delay, the new rules.

Hunter is asking Trump to consider repealing or suspending the rule or at a minimum move the filing deadline for new products back two years, from August 8, 2018, to August 8, 2020.

Farm and Food Production

Trump has previously expressed intent to overhaul FDA programs that govern farm and food production, and Congress could cut the agency’s budget, making it difficult or even impossible to fund programs to prevent food-borne infections, prevent misleading food labels, and keep unsafe additives out of the food supply.

However, the Food, Drug, and Cosmetic Act cannot be altered with an executive order, and President Trump may undoubtedly find out that there are limits to what he can really do.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources